Gene · 481
Papers3,412
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,412
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research on Potential Network Markers and Signaling Pathways in Type 2 Diabetes Based on Conditional Cell-Specific Network. | Genes (Basel) | 2022 | 35885938 | PubTator, text mining | PubMed |
| Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer's disease. | Neuron | 2022 | 35882228 | PubTator, text mining | PubMed |
| N-glycoproteomic profiling revealing novel coronavirus therapeutic targets potentially involved in Cepharanthine's intervention. | Med Nov Technol Devices | 2022 | 35879945 | PubTator, text mining | PubMed |
| C-terminal glutamine acts as a C-degron targeted by E3 ubiquitin ligase TRIM7. | Proc Natl Acad Sci U S A | 2022 | 35867826 | PubTator, text mining | PubMed |
| The ER protein Creld regulates ER-mitochondria contact dynamics and respiratory complex 1 activity. | Sci Adv | 2022 | 35867795 | PubTator, text mining | PubMed |
| Comprehensive profiling and characterization of cellular microRNAs in response to coxsackievirus A10 infection in bronchial epithelial cells. | Virol J | 2022 | 35864512 | PubTator, text mining | PubMed |
| Multi-Omics Integration-Based Prioritisation of Competing Endogenous RNA Regulation Networks in Small Cell Lung Cancer: Molecular Characteristics and Drug Candidates. | Front Oncol | 2022 | 35860558 | PubTator, text mining | PubMed |
| Evaluation of Transcriptomic Responses in Livers of Mice Exposed to the Short-Chain PFAS Compound HFPO-DA. | Front Toxicol | 2022 | 35832492 | PubTator, text mining | PubMed |
| Concordant and Heterogeneity of Single-Cell Transcriptome in Cardiac Development of Human and Mouse. | Front Genet | 2022 | 35832197 | PubTator, text mining | PubMed |
| Network analysis of synovial RNA sequencing identifies gene-gene interactions predictive of response in rheumatoid arthritis. | Arthritis Res Ther | 2022 | 35820911 | PubTator, text mining | PubMed |
| Single-nucleus RNA-Seq reveals singular gene signatures of human ductal cells during adaptation to insulin resistance. | JCI Insight | 2022 | 35819843 | PubTator, text mining | PubMed |
| Metabolic Disruption by Naturally Occurring Mycotoxins in Circulation: A Focus on Vascular and Bone Homeostasis Dysfunction. | Front Nutr | 2022 | 35811967 | PubTator, text mining | PubMed |
| COL5A1 Promotes the Progression of Gastric Cancer by Acting as a ceRNA of miR-137-3p to Upregulate FSTL1 Expression. | Cancers (Basel) | 2022 | 35805015 | PubTator, text mining | PubMed |
| Cryo-EM structures of recombinant human sodium-potassium pump determined in three different states. | Nat Commun | 2022 | 35803952 | Swiss-Prot, curated | PubMed |
| Multi-Modal Single-Cell Sequencing Identifies Cellular Immunophenotypes Associated With Juvenile Dermatomyositis Disease Activity. | Front Immunol | 2022 | 35799782 | PubTator, text mining | PubMed |
| Diabetes: how to manage diabetic peripheral neuropathy. | Drugs Context | 2022 | 35775075 | PubTator, text mining | PubMed |
| Nicotine-induced miR-21-3p promotes chemoresistance in lung cancer by negatively regulating FOXO3a. | Oncol Lett | 2022 | 35765274 | PubTator, text mining | PubMed |
| Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target. | Front Cardiovasc Med | 2022 | 35757325 | PubTator, text mining | PubMed |
| Human miRNAs to Identify Potential Regions of SARS-CoV-2. | ACS Omega | 2022 | 35755383 | PubTator, text mining | PubMed |
| Tumor Necrosis Factor Receptor Superfamily Member 21 Induces Endothelial-Mesenchymal Transition in Coronary Artery Endothelium of Type 2 Diabetes Mellitus. | Biomedicines | 2022 | 35740304 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/481/papers?page=18